Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q1 2026 · 10-Q
Revenue$1.11M$1.11M+27.5% vs Q1 2025 Net Income-$2.98M-$2.98MN/M vs Q1 2025 EPS Diluted-$0.35-$0.35N/M vs Q1 2025 Gross Profit$518,291+49.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flow-$2,846,825N/M Free Cash Flowderived-$2,917,226— Margins · derivedGross margin46.6%+6.9 pt vs Q1 2025
Operating margin-269.8%+42.6 pt vs Q1 2025
Net margin-268.3%+39.6 pt vs Q1 2025
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end